Print

New drug approved for metastatic prostate cancer

https://www.facingourrisk.org/XRAY/Pluvicto-Locametz-treatment-for-metastatic-prostate-cancer
Full article: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pluvicto-metastatic-castration-resistant-prostate-cancer

The FDA approved a new treatment for metastatic castration-resistant prostate cancer. They also approved a test that can be used to identify patients who would benefit from this new treatment.  (Posted 5/10/22)

Este artículo está disponible en español.

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following treatment studies are enrolling people with advanced prostate cancer: 

The following studies are enrolling people with advanced solid tumors, including prostate cancer: 

Other clinical trials for people with prostate cancer can be found here.

 

 


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.